Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion

Yoshihiko Maehara, Toshiro Okuyama, Yoshirio Kakeji, Hideo Baba, Motonosuke Furusawa, Keizo Sugimachi

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The effects of postoperative immunochemotherapy including the streptococcal preparation OK-432 on the rate of peritoneal recurrence and survival time after curative resection were studied in 36 patients with gastric cancer. Patients randomized to group B received 18 months of a therapy that is widely used in Japan for patients with gastric cancer: mitomycin C (MMC) and UFT, a combination of tegafur and uracil in a molar ratio of 1:4. Patients randomized to group A received the same drugs given to group B plus an intraperitoneal injection of OK-432 on postoperative day 0 and intradermal injections of OK-432 for 18 months at 2-week intervals. There were no differences between the two groups in any known prognostic factor or dose of any drug received, except for OK-432. There was no difference in the toxicity rates between the groups. The concomitant administration OK-432 and anticancer drugs significantly decreased the rates of peritoneal recurrence and lengthened survival time (P <0.05).

Original languageEnglish
Pages (from-to)36-40
Number of pages5
JournalThe American Journal of Surgery
Volume168
Issue number1
DOIs
Publication statusPublished - Jul 1994

Fingerprint

Picibanil
Stomach Neoplasms
Pharmaceutical Preparations
Tegafur
Recurrence
Intradermal Injections
Survival
Uracil
Mitomycin
Intraperitoneal Injections
Japan

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. / Maehara, Yoshihiko; Okuyama, Toshiro; Kakeji, Yoshirio; Baba, Hideo; Furusawa, Motonosuke; Sugimachi, Keizo.

In: The American Journal of Surgery, Vol. 168, No. 1, 07.1994, p. 36-40.

Research output: Contribution to journalArticle

Maehara, Yoshihiko ; Okuyama, Toshiro ; Kakeji, Yoshirio ; Baba, Hideo ; Furusawa, Motonosuke ; Sugimachi, Keizo. / Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. In: The American Journal of Surgery. 1994 ; Vol. 168, No. 1. pp. 36-40.
@article{28ed0f1d4b5141ee8a8e1ff65b0bd203,
title = "Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion",
abstract = "The effects of postoperative immunochemotherapy including the streptococcal preparation OK-432 on the rate of peritoneal recurrence and survival time after curative resection were studied in 36 patients with gastric cancer. Patients randomized to group B received 18 months of a therapy that is widely used in Japan for patients with gastric cancer: mitomycin C (MMC) and UFT, a combination of tegafur and uracil in a molar ratio of 1:4. Patients randomized to group A received the same drugs given to group B plus an intraperitoneal injection of OK-432 on postoperative day 0 and intradermal injections of OK-432 for 18 months at 2-week intervals. There were no differences between the two groups in any known prognostic factor or dose of any drug received, except for OK-432. There was no difference in the toxicity rates between the groups. The concomitant administration OK-432 and anticancer drugs significantly decreased the rates of peritoneal recurrence and lengthened survival time (P <0.05).",
author = "Yoshihiko Maehara and Toshiro Okuyama and Yoshirio Kakeji and Hideo Baba and Motonosuke Furusawa and Keizo Sugimachi",
year = "1994",
month = "7",
doi = "10.1016/S0002-9610(05)80068-6",
language = "English",
volume = "168",
pages = "36--40",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion

AU - Maehara, Yoshihiko

AU - Okuyama, Toshiro

AU - Kakeji, Yoshirio

AU - Baba, Hideo

AU - Furusawa, Motonosuke

AU - Sugimachi, Keizo

PY - 1994/7

Y1 - 1994/7

N2 - The effects of postoperative immunochemotherapy including the streptococcal preparation OK-432 on the rate of peritoneal recurrence and survival time after curative resection were studied in 36 patients with gastric cancer. Patients randomized to group B received 18 months of a therapy that is widely used in Japan for patients with gastric cancer: mitomycin C (MMC) and UFT, a combination of tegafur and uracil in a molar ratio of 1:4. Patients randomized to group A received the same drugs given to group B plus an intraperitoneal injection of OK-432 on postoperative day 0 and intradermal injections of OK-432 for 18 months at 2-week intervals. There were no differences between the two groups in any known prognostic factor or dose of any drug received, except for OK-432. There was no difference in the toxicity rates between the groups. The concomitant administration OK-432 and anticancer drugs significantly decreased the rates of peritoneal recurrence and lengthened survival time (P <0.05).

AB - The effects of postoperative immunochemotherapy including the streptococcal preparation OK-432 on the rate of peritoneal recurrence and survival time after curative resection were studied in 36 patients with gastric cancer. Patients randomized to group B received 18 months of a therapy that is widely used in Japan for patients with gastric cancer: mitomycin C (MMC) and UFT, a combination of tegafur and uracil in a molar ratio of 1:4. Patients randomized to group A received the same drugs given to group B plus an intraperitoneal injection of OK-432 on postoperative day 0 and intradermal injections of OK-432 for 18 months at 2-week intervals. There were no differences between the two groups in any known prognostic factor or dose of any drug received, except for OK-432. There was no difference in the toxicity rates between the groups. The concomitant administration OK-432 and anticancer drugs significantly decreased the rates of peritoneal recurrence and lengthened survival time (P <0.05).

UR - http://www.scopus.com/inward/record.url?scp=0028153407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028153407&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(05)80068-6

DO - 10.1016/S0002-9610(05)80068-6

M3 - Article

C2 - 8024097

AN - SCOPUS:0028153407

VL - 168

SP - 36

EP - 40

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -